Terns Pharmaceuticals
TERN
TERN
37 hedge funds and large institutions have $117M invested in Terns Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $174M → $117M (-$57.6M)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.24M | |
| 2 | +$1.01M | |
| 3 | +$832K | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$799K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$675K |
Top Sellers
| 1 | -$9.12M | |
| 2 | -$934K | |
| 3 | -$228K | |
| 4 |
STB
S&T Bank
Indiana,
Pennsylvania
|
-$104K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$87.7K |